Global · 2 views
Controversial US-backed vaccine trial in African newborns halted
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher…
AI Summary
The hepatitis B vaccine trial targeting newborns in Guinea‑Bissau, which was to be funded by the U.S. Centers for Disease Control and Prevention, has been halted. The study, backed by the United States, faced worldwide criticism before its cancellation.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Global
Continue reading recent Global coverage
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow